ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AXSM Axsome Therapeutics Inc

70.53
-2.55 (-3.49%)
Last Updated: 03:51:22
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Axsome Therapeutics Inc AXSM NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-2.55 -3.49% 70.53 03:51:22
Open Price Low Price High Price Close Price Previous Close
72.61 70.10 73.14 73.08
more quote information »

Recent News

Date Time Source Heading
15/4/202421:00GLOBEAxsome Therapeutics Highlights Innovative Neuroscience..
10/4/202421:00GLOBEAxsome Therapeutics to Report First Quarter 2024 Financial..
01/4/202422:00GLOBEAxsome Therapeutics Initiates ENGAGE Phase 3 Trial of..
25/3/202422:00GLOBEAxsome Therapeutics Announces Results of CRESCENDO..
25/3/202421:30GLOBEAxsome Therapeutics Announces AXS-12 Achieves Primary..
19/3/202422:00GLOBEAxsome Therapeutics Initiates PARADIGM Phase 3 Trial of..
05/3/202423:00GLOBEAxsome Therapeutics to Present at the Leerink Partners..
01/3/202410:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202410:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202409:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:00GLOBEAxsome Therapeutics to Present at the TD Cowen 44th Annual..
24/2/202400:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/2/202423:05EDGAR2Form 8-K - Current report
20/2/202423:00GLOBEAxsome Therapeutics Reports Fourth Quarter and Full Year..
20/2/202421:37IHMARKETNEWSMarket Cautiousness Ahead of Retail Giants’ Earnings; Oil..
15/2/202407:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202423:00GLOBEAxsome Therapeutics to Report Fourth Quarter and Full Year..
08/1/202423:10EDGAR2Form 8-K - Current report
04/1/202423:11EDGAR2Form 8-K - Current report
04/1/202423:00GLOBEAxsome Therapeutics Provides Preliminary Fourth Quarter and..
11/12/202323:00GLOBEAxsome Therapeutics Presents New Data and Post-Hoc Analyses..
08/12/202308:05EDGAR2Form 8-K - Current report
07/12/202323:00GLOBEAxsome Therapeutics Hosts Solriamfetol Virtual Investor..
22/11/202323:00GLOBEAxsome Therapeutics to Host Solriamfetol Virtual Investor..
21/11/202323:00GLOBEAxsome Therapeutics to Present at the Piper Sandler 35th..
07/11/202308:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202323:05EDGAR2Form 8-K - Current report
06/11/202323:00GLOBEAxsome Therapeutics Reports Third Quarter 2023 Financial..
06/11/202322:54IHMARKETNEWSMonday’s Wall Street Highlights: Berkshire Hathaway, Tesla,..
02/11/202322:00GLOBEAxsome Therapeutics and the Global Alzheimer’s Disease..
31/10/202322:00GLOBEAxsome Therapeutics to Present at Upcoming Investor..
24/10/202322:00GLOBEAxsome Therapeutics Presents Results of the ACCORD trial of..
12/10/202308:03EDGAR2Form 8-K - Current report
11/10/202322:00GLOBEAxsome Therapeutics Appoints Dr. Sue Mahony to its Board of..
10/10/202322:00GLOBEAxsome Therapeutics to Report Third Quarter 2023 Financial..
02/10/202322:00GLOBEAxsome Therapeutics Joins the National Alliance on Mental..
21/9/202321:00GLOBEAxsome Therapeutics Joins the Global Narcolepsy Community in..
16/9/202308:32EDGAR2Form 144 - Report of proposed sale of securities
16/9/202308:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202321:03GLOBEAxsome Therapeutics Highlights Commitment to Innovating..
05/9/202321:00GLOBEAxsome Therapeutics to Present at Three Upcoming Investor..
15/8/202321:45EDGAR2Form 8-K - Current report
08/8/202307:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202306:02EDGAR2Form 8-K - Current report
07/8/202321:00GLOBEAxsome Therapeutics Reports Second Quarter 2023 Financial..
05/8/202306:49EDGAR2Form 8-K - Current report
12/7/202321:00GLOBEAxsome Therapeutics to Report Second Quarter 2023 Financial..
08/7/202306:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/7/202322:21EDGAR2Form 8-K - Current report
07/7/202321:00GLOBEAxsome Therapeutics Initiates FOCUS Phase 3 Trial of..

Your Recent History

Delayed Upgrade Clock